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ABSTRACT
Equine herpesvirus (EHV) are the highly contagious pathogens that infect both domestic and wild equine populations
causing a major impact on equine industry worldwide. The methods for diagnosis of EHV have shown a vast
improvement in the last decade. Although some conventional techniques are still applicable in certain cases, most of the
clinical testing now focusing on rapid diagnosis by using the nucleic acid amplification-based techniques as major
advances for the detection of EHV. The diagnosis of EHV does not only depend on clinical situation alone, but the
suitability of diagnostic test is also vital for equine clinicians to make a decision regarding the specific treatments and
control measures to be taken. Therefore, crucial understanding of the strengths and limitations of each assay are needed
in order to interpret the results. Realizing the issue, this review intends to outline the clinical application of conventiona l
approaches and the progress of the new molecular approaches. Relative advantages and limitations of each method have
also been discussed.
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INTRODUCTION
Over sixty years, EHV-1 and EHV-4 are among
nine ubiquitous herpesviruses that pose the most serious
health risks for domestic horses.  The infections of these
two viruses result mainly in upper respiratory tract
disease, abortion and neurological disease. The diagnosis
of EHV infection depends mostly on laboratory
techniques in addition to clinical signs and historical
disease. The clinical manifestations of EHV infection are
similar to the infection of equine influenza, equine
arteritis virus (EAV), equine adenovirus, equine
protozoal myeloencephalitis, eastern equine encephalitis
(EEE) and West Nile virus encephalitis (Powell, 1991).
Therefore, the differential diagnosis of EHV infection is
crucial for the prevention and control of the disease. A
traditional technique of virus isolation formed a
foundation of diagnostic virology. However, it has often
constrained by expense, turnaround time and low
sensitivity. Serological techniques are much more rapid,
economical, easy to perform and suitable for screening
purposes for EHV but most of these assays are unable to
differentiate between infected and vaccinated animals and
false-positive results are to be expected. Advance
progresses in new diagnostic tools have provided a vast
improvement in EHV detection with newer molecular-
based assays such as real-time polymerase chain reaction
(Pusterla et al., 2017; Hafshejani et al.,2015) and loop-
mediated isothermal amplification (LAMP) (Kinoshita et
al., 2016) as the highly sensitive and specific in favoured
to previously time-consuming and laborious methods.
Molecular tools for the detection of equine herpesvirus
detection has been very used recently (Laabassi et al.,
2017; Badenhorst et. al., 2015). Equine practitioners
should fully understand the advantages and the
limitations of available tests beforehand in order to
provide an accurate result interpretation. This review
intends to demystify diagnostic approaches for equine
herpesviruses detection from an insight of conventional
to recent approaches. Further, advantages and limitations
of these methods has also been discussed.
CONVENTIONAL TECHNIQUES
Virus Isolation: Virus culture and isolation remained as
the gold standard for laboratory diagnosis of EHV
infections. The technique demonstrates the typical
cytopathic effect (CPE) in susceptible cell cultures
inoculated with sample supernatant and use concurrently
with the rapid test of polymerase chain reaction (PCR) or
Immunoassays. Besides sample type and handling, one of
the most important criteria to consider when isolating the
virus is the type of cell culture. EHV-1 infects a variety
of non-equine derived cell type such as fetal kidney cells,
lung cells, dermal fibroblasts and endothelial cells from
human, porcine, bovine, canine, feline, and rabbit (Trapp
et al., 2005). The common cell used to isolate EHV-1 are
rabbit kidney (RK-13), baby hamster kidney (BHK-21),
Madin-Darby bovine kidney (MDBK), and pig kidney
(PK-15) (OIE, 2012). Unlike EHV-1, EHV-4 is mainly
restricted to equine-derived cells such as equine dermis
(ED), equine embryonic lung (EEL) and equine foetal
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kidney (EFK) (Allen et al., 2004). Despite of it all, some
studies have shown that EHV-4 is capable of growing in
the Vero cell (Dynon et al., 2007; Ploszay et al., 2013).
Nevertheless, it is important to understand that different
cell lines have different sensitivity which could cause
false negative results (Balasuriya et al., 2012) and thus,
the most susceptible cell must be favoured especially if
the infrequent cases of EHV-4 abortion are to be
detected. The alphaherpesviruses, EHV-1 and EHV-4
produce CPE characterised by rounding and clumping of
cells, the detachment of cells, and multinucleated
syncytial cells within at least one to two days post-
infection of high viral load sample (Crabb et al., 1995;
Lunn et al., 2009). The presence of the virus in cell
culture is confirmed with PCR.
Isolation of EHV-1 from nasal swabs or
peripheral blood mononuclear cells (PBMC) from
clinically infected horses could provide robust evidence
of the viral infection. For EHM suspected case, it is
recommended to collect the nasal swab sample during the
early stages as the neurological signs start to appear at the
end of viremia phase. The virus also can be detected in
PBMC during the viremia phase before the horse start to
develop the neurologic signs. As for suspected case of
EHV-1 abortion, tissues samples such as placenta, lung,
liver, thymus and spleen from the aborted foetus the virus
isolation can be attempted for virus isolation.
Periodically, the virus is also presence in the
cerebrospinal fluid (CSF) along with neurological signs
(7-16 dpi) but it is rarely collected since isolation is
difficult (Kohn et al., 2006).
The viability of the virus is required in the
sample and it may be affected by factors such as sample
collection and storage, timing of sample collection, post-
mortem interval and sample transport (Bourgeois and
Oaks, 2013). For nasal swab, it is recommended to take
the sample during the initial febrile phase and
instantaneously transport them in sterile cold transport
medium (Pusterla et al., 2008). Blood sample intended
for buffy coat separation should not be frozen while
tissue samples should be kept at 4°C instead of -20 °C
until inoculated into cell culture. Samples that will not be
processed immediately should be stored at -70°C (OIE,
2012). The result of virus isolation may be negative due
to procedural mistakes that could have affected the viral
envelope integrity; a crucial component for host infection
(Goehring et al., 2010). It is also due to intermittent of
virus shedding and interference of local antibodies
(Harless and Pusterla, 2006).
The reactivation of latent infection in vitro can
be done by co-cultivation method and has been
considered as gold standard for demonstration of latent
virus. Latently infected tissues should be dispersed to
yield infectious virus and the viable tissue cells will be
cultured and serially passage for three times with
susceptible cells. The sensitivity of co-cultivation method
can be increased for latently infected leukocytes by
stimulation with T-cell mitogens (Slater, 2013).
In the diagnostic lab, virus isolation helps to
determine the status of the infections (lytic or latent) from
the DNA in PCR test. The failure to isolate the virus
could be explained as a latent infection or the infected
horse harbours the virus in an inactive form in the body.
While rapidness and specificity are unquestionable
advantages of PCR over virus isolation, the superiority of
PCR sensitivity could be argued as the virus isolation
may provide higher sensitivity than PCR if the viable
virus is presence in the sample and suitable cell lines are
used for cell culture. This is due to larger volume of the
sample inoculate onto the cell (50 to 150ml) than that
being used in PCR. McBrearty et al. (2013) were able to
isolate EHV-4 from PCR-negative samples which suggest
that the sensitivity of virus isolation has a potential to
surpass the PCR. However, the likelihood of
simultaneous detection and differentiation of various
types of EHV and rapid diagnosis offered by PCR is
considered substantial over virus isolation technique
under certain circumstances. Besides time-consuming and
laborious, virus isolation requires the presence of viable
virus which can be challenging to achieve in the field. In
summary, as the conventional technique of cell culture is
considered insufficient to produce a reliable result, more
advanced techniques should be concurrently utilised.
Serology-Based Assay: Serological testing for EHV
antibodies in serum or plasma has been the key tool to
gain retrospective diagnosis and forms a valuable part of
longitudinal surveillance. Serology helps to provide
information on EHV-1 exposure in a non-vaccinated
horse which  can be used to guide the management
practices (Irwin et al., 2007). Despite some limitations,
most serologic assays are still reliable and useful for viral
diagnosis, cost-effective and fairly easy to perform. Over
the years, a variety of serology methods has been used in
the detection of EHV antibodies including the most
common test formats for equine virus diseases, virus
neutralization (VN) and enzyme-linked immunosorbent
assay (ELISA), which will be discussed in details with
several other serologic tests.
Enzyme-Linked Immunosorbent Assay (ELISA):
ELISA is one of the most common serologic tests used as
a screen test in detection of many infectious diseases. In
ELISA, the antigen is bound to the wells of the plastic
plate. The serum samples are added, and if EHV-1 or
EHV-4 are present, they will bind to the antigens.
When unbound antibody are washed, a
secondary antibody against antibody such as anti-equine
immunoglobulin G (IgG) conjugated to an enzyme like
horseradish peroxidase is added afterwards and becomes
a complex with these antibodies. Unbound antibodies will
be removed prior the addition of a substrate solution. The
addition of colorimetric substrate produces a visible
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colour change which indicates the positive reaction. The
results can be interpreted visually or by microplate
spectrophotometer.
Theoretically, detection of EHV-1 specific
antibody would provide a more convenient way to
identify latently infected horses. Earlier ELISA assays,
like other serologic assays, did not discriminate between
EHV-1 and EHV-4 because of the close antigenic
similarity between these two strains. Through recent
advance, a type-specific ELISA using fusion proteins
expressing variable regions of glycoprotein G (gG)
homologues has been developed and able to distinguish
antibody to EHV-4 and EHV1 (Crabb et al., 1995; Crabb
and Studdert, 1993). It has been shown to be a valuable
diagnostic tool to identify horses infected with EHV1 or
EHV4 when acute and convalescent sera are available.
The IgG ELISA has been used in the epidemiological
studies of EHV infection (Gilkerson et al., 1999;
Yasunaga et al., 1998) as well as in the management of
outbreaks of EHV-1 myeloencephalitis and abortion
(Drummer et al., 1995; Studdert et al., 2003). A
commercial ELISA test kit has been developed using
EHV-1/4 recombinant glycoprotein G for the detection
and distinguishing EHV-1 and EHV-4 infections such as
Svanovir® and has been used broadly in to detect EHV-1
and EHV-4 infections (Ataseven et al., 2009; Brown et
al., 2007; Dynon et al., 2007; Gür and Yapici, 2008).
However, a correlation between the virological
and serological diagnosis of EHV-1 using ELISA gG was
reported as relatively poor. It is assumed that EHV-1
specific antibody presumably maintained by latently
infected horses do not recognise gG and some antibody
are below the detection limits of this assay, explaining the
low levels of EHV-1 antibody (Dunowska et al., 2015).
Virus Neutralization: Virus neutralization (VN) test
detects antibodies capable of neutralizing the infectivity
of the virus. This technique involves a serial dilution of
heat-inactivated serum followed by incubation with 100-
200 TCID50 virus which leads to neutralization of the
virus with antibodies. The mixture is added into the cells
to see any infection (Bourgeois and Oaks, 2013). The
presence of the viral growth is examined microscopic for
the evidence of cytopathic effect (CPE). In the case of the
low amount of virus present in the cell or no CPE
observed, immunofluorescence staining should be
applied. By neutralizing the infectivity of the virus,
antibody protects the cells against viral infection. The
highest dilution that neutralized virus infectivity known
as the titre (Murphy et al., 1999).
The detection of specific antibody in serum
required more than a single blood collection as it is
insufficient for a positive diagnosis of current and active
infection. The diagnosis of acute EHV-1 cases by VN is
reliable if the sampling is conducted during the onset of
the disease. Therefore, it is recommended to collect a
paired serum samples from in-contact horses since many
of these animals seroconverts, showing indirect
indication of EHV-1 infection (Pusterla et al., 2009a).
The acute phase sera sample should be taken after the
beginning of clinical signs followed by convalescent
phase sera taken two to four weeks after.  Fourfold or
greater increase in virus-specific antibody titre is needed
to confirm the infection (OIE, 2012). According to
American Association of Equine Practitioners, high titers
in a single VN between 1:1024 to 1:2048 or greater are
most probably demonstrate the recent infection rather
than vaccination. Moreover, VN test is suitable to be used
in prevalence surveys as it is capable of indicating the
historical exposure of the infection (Slater, 2013).
Complement Fixation: The complement fixation (CF) is
a method used to detect the presence of specific antibody
such as IgM or antigen in the serum. CF test depends on
formation of specific antibody-antigen complex in which
during the reaction, complement will bind or fix to it.
Sensitized sheep red blood cells are added to measure the
complements that have bound in the reaction. If the
complements have been fixed due to the antigen-antibody
reaction, there will be no complements remain for the
lysis of the sensitized sheep red blood cell and no
haemolysis indicates the positive result.
CF, along with other serological assays is
suitable for ascertaining antibodies against EHV-1 or
EHV-4. CF antibodies have low vitality which is
normally untraceable for three months when infection
happen (Thomson et al., 1976). Hence, it is visibly
effective during the outbreak by utilizing two pairs of
collected sera within a fortnight apart as it is capable in
providing the most powerful serological evidence for
early EHV-1 infection (Hussey et al., 2006; McCartan et
al., 1995). Epitopes recognized by CF antibodies,
however, can be cross-reactive with EHV-1 and EHV-4,
leading to a false result of type differentiation (Crabb and
Studdert, 1993).
Immunofluorescence: Immunofluorescence (IF) is a
technique to detect specific target antigens in nasal or
nasopharyngeal swab samples or in frozen (cryostat)
sections from aborted fetal tissues (lung, liver, thymus
and spleen) and placental tissue in the detection of EHV
using the fluorescent-labelled antibodies. In IF
techniques, the sections are mounted on microscope
slides, fixed with acetone and incubated at 37°C treated
with a proper dilution of the swine antibody specific for
EHV-1 which formed chemically with fluorescent dyes
such as fluorescein isothiocyanate (FITC) or
tetramethylrhodamine isothiocyanate (TRITC). These
marked antibodies attach (directly or indirectly) to the
antigen of interest which enables the detection of antigen
via fluorescence microscope (Robinson, 2009) (Figure 1).
One of the advantages of IF is it is very rapid and simple
test with acceptable sensitivity and specificity. Direct
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immunofluorescence detection of EHV-1 or EHV–4
antigens in cryostat sections of tissues freshly dissected
from aborted foetuses offers a rapid technique for the
diagnostic laboratory to conduct an early diagnosis of
EHV abortion (Allen et al., 2004). Usually, IF is
combined with histopathology for the confirmation of the
viral antigen. In addition, it can demonstrate antigen
which related to lesions or affected tissues which are the
additional evidence that implies the connection to the
lesion. The detection of viral protein is typically
characteristic of active replication, instead of the latent
infection. Therefore, detection of viral antigen in post-
mortem fresh, frozen or fixed samples of lymph nodes
and trigeminal ganglia during latent infection is
theoretically producing negative results. The major
disadvantage includes the visualization of the lesion from
the poor morphology of frozen sections which can be
technically challenging to read (Bourgeois, 2013).
Immunohistochemistry: Enzyme immunohistochemical
staining such as immunoperoxidase has been established
as a technique for detecting EHV-1 antigen paraffin-
embedded tissue of aborted equine foetuses or
neurologically affected horses. Furthermore, it also can
be attempted on infected cell monolayers for both EHV-1
and EHV-4 detection (van Maanen et al., 2000). The
technique particularly useful for evaluation of
morphological lesions associated with EHV-1.
Histopathology: Histopathology is a crucial method for
confirming EHV infection in aborted foetuses and post-
mortem samples collected from neurologically affected
horses. The characteristic of the virus usually includes
eosinophilic inclusion bodies in airway epithelial and
hepatocytes from aborted foetuses (Rimstad and Evensen,
1993). Infection of the vascular endothelium causes
necrotising vasculitis, thrombosis and ischemia damage
of blood capillaries in the spinal cord or brain and
endometrial blood vessels (Edington et al., 1991; Jackson
et al., 1977; Smith et al., 1992; Wilson, 1997).
In-Situ Hybridization (ISH): Viral DNA can be
detected by in-situ hybridization (ISH). ISH in
combination with polymerase chain reaction (PCR) have
been applied to samples of foetal and placental tissue
from EHV-1 abortions. This assay is able to expose viral
nucleic acids in endothelial cells of endometrial arterioles
(Mukaiya et al., 2000; Smith and Borchers, 2001). DNA-
DNA ISH has higher sensitivity than IHC and has the
possibility to detect latent and active infected cells.
However, experimental evidence suggests that the
technique is lacking in sensitivity to detect low amount of
virus genomes in latently infected cells and more
sensitive RNA-DNA hybridization assay should be used
(Slater, 2013).
Molecular approaches: Latency by alphaherpesviruses
is seen as an important epidemiological plan to secure
vitality while expanding inside the natural host
population (Whitley and Gnann, 1993). The latency site
for EHV-1 and EHV-4 have been found in the lymphoid
tissue debilitating the respiratory tract (Chesters et al.,
1997; Edington et al., 1994; Slater et al., 1994) and in the
peripheral blood (Chesters et al., 1997; Smith et al.,
1998; Welch et al., 1992). Other studies claim latency is
established mainly in the trigeminal ganglia (Borchers et
al., 1999; Slater et al., 1994). During latency, the entire
viral genome exists inside the host cells but only a few
part is transcribing into detectable viral RNA, known as
latency-associated transcripts (LATS). This features of
EHV renders the conventional methods of detecting the
virus in the latent form. Molecular-based approaches are
evidently more sensitive and specific, which have
provided a rapid and accurate detection and
characterization of EHV. By targeting these LATs,
latency can be detected by using reverse transcriptase-
polymerase chain reaction (RT–PCR) or by real–time
PCR. From the past decades, diagnosis by PCR including
nested, multiplex PCR and quantitative PCR have form a
vital part of the range of diagnostic tests currently
available for EHV. The advent of the latest technology of
loop-mediated isothermal amplification (LAMP) has
great potential to emerge as a new approach for a rapid
diagnostic tool for early detection and identification of
EHV.
Conventional Polymerase Chain Reaction: PCR in
detection of EHV-1 and EHV-4 is considered superior to
virus isolation in terms of rapidness, sensitivity and
specificity (Diallo et al., 2007; Marenzoni et al., 2008;
Varrasso et al., 2001). The assay is able to detect 10 to
100 copies of target viral (Borchers and Slater, 1993) and
produce a positive result although the testing with virus
isolation is negative due to the low magnitude of viral
load (Lunn et al., 2009). The sensitivity of PCR is
suitable for consensus study involving tissue samples in
previously characterized EHVs as well as providing new
sequence information for previously unreported EHVs
(Leon et al., 2008).
Nested, semi-nested PCR (Borchers and Slater,
1993; Pusterla et al., 2005; Varrasso et al., 2001) and
multiplex nested PCR (Ataseven et al., 2009; Carvalho et
al., 2000; Wang et al., 2007) for detection of EHV have
been described. The nested PCR has higher sensitivity
than standard PCR, but extreme sensitivity of nested PCR
is prone to yield false positive results from a minute
amount of previous amplicons contamination (Bourgeois
and Oaks 2013). Therefore, the use of a nested PCR assay
is not recommended for the routine laboratory diagnosis
of EHV-1. Multiplex PCR could simultaneously detect
multiple EHV isolates (Carvalho et al., 2000; Wang et
al., 2007) and equally sensitive and specific for detection
of EHV with reduced labour and reagents cost compared
to single PCR assays (Edwards and Gibbs, 1994).
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Reverse-transcription PCR (RT-PCR) assay also have
been used to differentiate between the active and latent
infections of EHV-1 by detection of transcripts of EHV-1
glycoprotein B (Allen et al., 2008). Since EHV-1 is a
DNA virus, this type of PCR is rarely used to detect lytic
infections but more likely for detecting and quantifying
latent EHV-1 in tissues and whole blood (Borchers et al.,
1999; Chesters et al., 1997). The sensitivity of RT-PCR
can be increased by using semi-nested, nested or three-
step nested.  However, due to the complexity and time
consumption of this method, it is regularly used in
research setting rather than in routine diagnosis.
Several PCR assays target different target genes
of EHV; glycoprotein gene B (gB), C (gC), D (gD), H
(gH) and thymidine kinase (TK) gene have been
developed (Borchers and Slater, 1993; Carvalho et al.,
2000; Lawrence et al., 1994; Varrasso et al., 2001).
Detection of EHV has been attempted in clinical or
pathological specimens such neonatal foal tissues, blood
leukocytes, nasal mucus, brain and spinal cord,
inoculated cell cultures and paraffin-embedded archival
tissues (Brown et al., 2007; Kirisawa et al., 1993;
Lawrence et al., 1994; Rimstad and Evensen, 1993;
Sharma et al., 1992; Studdert et al., 2003). According to
World Organisation for Animal Health (OIE), PCR
methods are most useful for the confirmation of the virus
in the samples of aborted foetuses, nasopharyngeal swabs
and peripheral blood leukocytes of foals and yearlings for
diagnosis of active EHV infection. In neurological
diagnosis, PCR is important in examinations of the spinal
cord, brain tissue and PBMC.
The EHV could shed intermittently in the body
without showing any clinical signs and thus, collecting
the samples from asymptomatic horses outside the
outbreak for PCR testing is not recommended (Lunn et
al., 2009). Tested horse that has been exposed and
latently infected could cause a confusion in clinical
evaluation as it may continuously produce the positive
result for a long time. The complexities of a test
clarification could put the equine practitioner in a hard
situation when taking the decision regarding the facilities
confinements or the annulment of the competitions.
Isolation and close monitoring for clinical signs
development however should be done when the high risk
asymptomatic horses were positive in nasal secretion by
PCR during the outbreak. This is because, under such
circumstances, the magnitude of virus during incubation
period resembles with that subclinical stage (Pusterla et
al., 2009a).
The drawback of the non-quantitative PCR is the
incapability to measure the viral load in the clinical
sample has led to a newer molecular platform of
quantitative PCR assay with promising advantages for
EHV detection. In addition, the standard PCR is
incapable of distinguishing between latent and lytic
infection. Although extensive development for PCR
assays has been made, the lack of standardization of the
laboratory and quality assurance procedures persist to be
constant challenges.
Real Time PCR: Quantitative PCR or real-time PCR
(qPCR) was developed in 1996 using a probe-based
detection system and enables the PCR amplification in a
closed-tube system (Wilhelm and Pingoud, 2003). The 5'
nuclease activity of Taq polymerase will digest the probe
during the primer extension, causing the release of
quenched fluorescent signal which is measured
continuously by sequence detector during each PCR
amplification cycle (Heid et al., 1996). The fluorescent
signals are collect by a digital camera in real time and the
data is stored in the attached computer (Pusterla et al.,
2006). Presently, variety fluorescent chemistries such as
SYBR Green dye, Fröster resonance energy transfer
(FRET) and Scorpion primers can be used as the
alternatives to TaqMan with similar performance
characteristics.
Compared to conventional PCR, qPCR provide
a lower risk of cross-contamination due to its close and
automatized amplification system. The high technology
offered by this assay, however, requires some initial high
capital costs for instruments such thermal cycler which
most of the low resource setting laboratory could not
afford.
In the recent study of EHV detection, qPCR is in
favoured of virus isolation and other assays in terms of
sensitivity, specificity and rapidity specificity and allow
the quantification of virus load for EHV in clinical
samples (Allen and Breathnach, 2006; Diallo et al., 2007;
Elia et al., 2006; Hussey et al., 2006; Marenzoni et al.,
2008; Perkins et al., 2008; Pusterla et al., 2009b). The
ability to quantify viral load is valuable for a prominent
characterization of disease phase, evaluation of risk
exposure in susceptible horses and control measures and
vaccination evaluation through measurement of viral load
and viral shedding. qPCR has been used to demonstrate
differences in the viral loads between disease stages in
adult horses and amongst clinically and subclinically
infected horses (Pusterla et al., 2008). The viral loads of
EHV-1 in nasal secretions are varying between horses.
Previous assessments of the peak of viral DNA in the
nasal secretion of EHV-1 infected horses using qPCR
were approximately 4.2×104 (Pusterla et al. 2009) and 10
(Hussey et al. 2006) gB gene copies per 1 ng of template
DNA. It is difficult to get the exact values due to different
stages of disease progression and sampling method
between the studies.
The advanced in quantitative real-time PCR
enables the discrimination between two viral states. The
differentiation between latent and lytic infection rely on
identification of the viral genome (DNA) and viral
transcripts (mRNA) for one of the structural genes.
Detection of viral DNA without the viral mRNA
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indicates the latent virus while detection of both viral
DNA and mRNA demonstrate an active EHV infection.
In a previous study, the expression of the structural
glycoprotein B in nasal swabs of the infected foal was
detected only during the first week of the 28 days study
period after the onset of the clinical signs. There is no
persistence of LAT expression was recorded within the
period, suggesting that the lytic infection of EHV-4 can
be marked either by high DNA load or by detection of the
transcriptional activity of the glycoprotein B (Pusterla et
al., 2005).
A real-time PCR have been utilised in the
variety of samples including nasal swabs, blood, tissues,
lymph nodes, trigeminal ganglia, placenta, brains, lungs,
liver and spleen (Allen et al., 2006, 2007; Hussey et al.,
2006; Sarani et al., 2013; Turan et al., 2012). A study has
suggested that the detection of EHV-1 using qPCR assay
of nasal secretions is more sensitive than assay of buffy
coat leukocytes (Brown et al., 2007) but greater
sensitivity in peripheral blood mononuclear cells was
observed (Hussey et al., 2006). Meanwhile, EHV-4 has a
low load, lack of viral replication and short duration in
peripheral blood leukocyte (PBL), suggesting that it is
not suitable to use as a diagnostic material to detect acute
EHV-4 respiratory infection (Pusterla et al., 2005).
The real- time PCR could detect active nasal
viral shedding or viremia but is generally fail to detect
latent infection. As the positive real-time PCR indicate
active infection, it is therefore categorized as potentially
contagious infection, in which this characteristic is
important for the diagnosis of EHV-1 (Hussey et al.,
2006).
The development of a real–time PCR assay
using allelic discrimination E2 to distinguish between
neuropathogenic and non–neuropathogenic strains of
EHV1 has been reported (Allen et al., 2008). The
following study managed to tackle the lack of sensitivity
for routine diagnostic applications by using allelic
discrimination E1in the open reading frame 30 (ORF30)
which showed 10-fold-higher sensitivity than E2 allelic
discrimination (Smith et al., 2012).
The target of the conserved regions in
conventional real-time PCR can be too short and
problematic. Moreover, variants with unidentified
polymorphisms in the conserved regions could be
undetected. By introducing the minor groove binder
(MGB) probe technology, it allows the shorter probes to
descry short conserved regions when developing assays
to discover various strains. The post-amplification melt-
curve analysis is allowed by 5’-MGB probe to confirm
the real-time amplification results (Corpus, 2010).
Loop-mediated Isothermal Amplification (LAMP):
LAMP is a nucleic acid amplification method that
amplifies DNA with high specificity, efficiency, and
rapidity under isothermal condition (Parida et al., 2008).
It requires four to six different primers that are designed
specifically to recognize six to eight specific gene
sequences. The DNA amplification is accomplished with
the use of DNA polymerase with strand-displacing
activity using only a water bath or heating block to
incubate the reaction mixture at a constant temperature
between 60-65°C (Notomi et al., 2000). Exclusion of
expensive instruments demands in LAMP amplification
has changed the ways on how the researchers are able to
conduct the testing outside the laboratory setting. A
further prominent advantage of LAMP assays is the
omission of DNA extraction steps which allows the
reaction to be carried out directly from the samples, thus,
reduce the turnaround time, cost and labour (Nemoto et
al., 2011).
The amplification of DNA can be seen with the
naked eye in the form of turbidity (Figure 2C) or visual
fluorescence (Figure 2D). Positive LAMP amplification
can be indicated by the synthesis of a large amount of
white precipitate magnesium pyrophosphate in the
reaction which causes the turbidity, or by the colour
change after the addition of DNA binding dye such as
SYBR Green, calcein, ethidium bromide, PicoGreen or
propidium iodide (Mori et al., 2001). Gene amplification
products also can be detected by agarose gel
electrophoresis in which a ladder pattern of varying sizes
of bands are produced (Figure 2B). Such pattern is due
the cauliflower-like structures with multiple loops formed
by annealing between alternately inverted repeats of the
target in the same strand (Notomi et al., 2000).
Furthermore, LAMP assays also allow the quantification
of the template DNA by real-time turbidimetry (Mori et
al., 2004) (Figure 2A). In 2006, visual detection of
LAMP product in a sequences specific manner through
precipitation by cationic polymers, polyethylenimine
(PEI) has been reported (Mori et al., 2006). Moreover,
further improvement has been used to detect the
magnesium pyrophosphate by-product based on
colorimetry using hydroxynaphthol blue (HNB) indicator
(Goto et al., 2009). For the confirmation of the structure,
the amplified product is digested using several restriction
endonucleases such as BamHI, PvuI and PvuII which
each one of them cut at different regions. Confirmation
also can be done by cloning and sequencing (Notomi et
al., 2000).
Since the first report of LAMP in 2000, this
molecular method has become a focus among the
researchers due to the specific features, which favour its
use in simplified testing systems that might be
appropriate in a resource-limited setting in developing
countries, where the lethal tropical diseases are endemic
(Mori et al., 2013). In 2010, the application of LAMP for
the rapid detection of both EHV-1 and EHV-4 from nasal
swab has been conducted (Nemoto et al., 2010). The
result using LAMP has shown to be in good agreement
with PCR for EHV-1 and EHV-4. Despite all the
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advantages, the main limitation of the LAMP is the
primer designing of four to six primers which are crucial
for a successful amplification. Hybridization of the four
main primers to the target DNA is considered critical for
the LAMP efficiency. Furthermore, LAMP is unsuitable
to be used for the detection of unknown or unsequenced
targets. In addition, the other important thing to consider
using this assay is the size of the target DNA. While PCR
could amplify the region of target DNA up to 2kb, LAMP
is only limited within the range of less than 300 base pair
because one rate limiting step for amplification in this
method is strand displacement DNA synthesis (Notomi et
al., 2000). However, due to the use of simple rapid and
efficient method of LAMP, the assay could be considered
as an alternative to previous methods of detecting the
EHV where it would enormously support control
programs and management during outbreak which could
limit the spread of the disease.
Table 1. Summarized the comparison of conventional and molecular methods for detection of equine herpesvirus.
Diagnostic test Rapidity
(Yes/No)
Required Sample Advantages Disadvantage
Immunoflorescence Yes Airway swabs,
Frozen tissue, fresh
blood
Simple, fair sensitivity; high
specificity; suitable for
screening test for tissue and
swabs
False negative occur;
interpretation of results are
challenging; required
skilled personnel
Virus Isolation No Fresh blood





















Paired sera taken 10-










False positive occur due to
previous vaccination and
maternal antibodies
Histopathology No Fixed tissue sections Specific and sensitive




























of virus load; detection of
multiple classes of genes;







Yes Airway swabs, blood Highly specific and
sensitive; less sensitivity to
inhibitory substances present




(requirement for four to six
primers); inadequate for the
detection of unknown or
unsequenced targets.
CN, complement fixation; ELISA, enzyme-linked immunosorbent assay; VN, virus neutralization; PBMC, peripheral blood
mononuclear cells
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Fig.1. Schematic representation of direct and indirect immunofluorescence
Fig.2. Monitoring of LAMP amplification. (A) The turbidity of magnesium pyrophosphate, a by-product of the
reaction, can be detected real-time by a real-time turbidimeter. (B) Agarose gel analysis revealing the
typical electrophoresis pattern of LAMP amplified product, which is not a single band but a ladder
pattern because the LAMP method forms amplified products of various sizes consisting of alternately
inverted repeats of the target sequence on the same strand. (C) Visual turbidity in the form of white
precipitate as observed in positive control due to accumulation of magnesium pyrophosphate in
proportion to the accumulated amplified products. (D) When the tube containing the amplified products
incorporating a fluorescent intercalating dye is illuminated with a UV lamp, the fluorescence intensity
increases. Reproduced from (Parida et al. 2008), with permission from the publisher (Wiley).
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Conclusion: Table 1 summarized the comparison of
conventional and molecular methods for detection of
equine herpesvirus comprising the advantages and
disadvantages as each of the tests that have been
discussed. The conventional approaches have been well-
developed and used widely for testing and still applicable
to be used despite their limitations. Molecular assays
have become the powerful tools for virus diagnostic but
when new applications for molecular testing are being
introduced, the questions arise whether they can supplant
the traditional methods in term rapidity, sensitivity and
cost of the test. The newer molecular methods show a
promising technology but extensive evaluation is needed
in order to be fully implemented in a routine diagnostic.
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